Search results (200)
« Back to NewsWIMM Day 2026: connecting people, ideas and scientific discovery
26 June 2026
- Centre for Computational Biology
- Department of Oncology
- Grants & Awards
- MRC MHU
- MRC TIDU
- NDCN
- NDM
- NDWRH
- RDM
On Tuesday 23rd June, the MRC WIMM community came together at Saïd Business School for the Institute's annual away day, sharing research, professional achievements and much more.
Professor KJ Patel awarded major European Research Council Advanced Grant
23 June 2026
Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.
Professor Adam Mead joins Oxford Cancer leadership team
15 June 2026
Congratulations to Adam Mead, who has been appointed Director of Oxford Cancer. Professor Mead joins Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community.
Study reveals blood stem cells can ‘remember’ inflammation
27 May 2026
Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers
Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies
19 May 2026
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.
Deputy Directors of the MRC Weatherall Institute of Molecular Medicine
7 May 2026
Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.
Congratulations to our new Associate Professors
7 May 2026
MRC WIMM is delighted to announce the conferment of two new Associate Professorships. Our newly appointed Associate Professors have been recognised for their outstanding contributions to research, teaching, and citizenship within the University and beyond.
2026 Genome Engineering Forum brings together Oxford research community
20 April 2026
The Genome Engineering, Virus Production and Transgenics Facility at the MRC Weatherall Institute of Molecular Medicine (WIMM), together with the MRC Mary Lyon Centre, recently organised the 2026 Genome Engineering Forum at the MRC WIMM, bringing together over 100 academic researchers, staff and students from across Oxfordshire.
Onima Chowdhury receives Cancer Research UK clinical trial grant
8 April 2026
Congratulations to Dr Onima Chowdhury, who has been awarded a clinical trial grant by Cancer Research UK to improve treatment of Myelodysplastic Syndromes.
Verena Korber receives CRUK Career Development Fellowship
1 April 2026
Congratulations to Dr Verena Korber, who has been awarded a Career Development Fellowship from Cancer Research UK.
DNA-damaging formaldehyde accelerates blood ageing by extinction of stem cells
23 March 2026
Researchers from the University of Oxford, the German Cancer Research Center, and Hospital Saint-Louis have uncovered a surprising new way that blood stem cells are lost over time, offering fresh insight into ageing and diseases that affect blood production.
Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment
23 March 2026
Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.
New study reveals how blood cell production responds to parasite infection
11 March 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
New bone marrow model offers scalable platform for next-generation drug discovery
23 February 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long-term blood and immune cell production in a fully human 3D system.